Virus-inhibitory activity of 6-azauridine dependent on cell-free extracts containing uridine kinase. II. Quantitative aspects, efficacy of pretreatment.
D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology*; D001103:Arboviruses / Q000187:drug effects* / Q000254:growth & development / Q000472:pathogenicity; D002286:Carcinoma, Ehrlich Tumor; D002474:Cell-Free System; D002642:Chick Embryo; D046508:Culture Techniques; D003588:Cytopathogenic Effect, Viral; D006564:Herpesviridae / Q000187:drug effects* / Q000254:growth & development / Q000472:pathogenicity; D051379:Mice; D009522:Newcastle disease virus / Q000187:drug effects* / Q000254:growth & development / Q000472:pathogenicity; D010770:Phosphotransferases / Q000494:pharmacology*; D014020:Tissue Extracts / Q000494:pharmacology*; D014227:Triazines / Q000494:pharmacology*; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D014020:Tissue Extracts; D014227:Triazines; D010770:Phosphotransferases